What The Study Did: Prostate biopsy and prostate cancer diagnosis rates decreased during the COVID-19 pandemic, with no statistically significant changes in rates by race in this study that included 51,000 men in the Veterans Affairs Health Care System.
Authors: Zachary Klaassen, M.D., M.Sc., of Augusta University in Augusta, Georgia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2022.0467)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0467?guestAccessKey=92f3e2d1-bd5c-46de-bd55-7c4bb72dcb11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722
JAMA Oncology